XOMA CORPORATION (NASDAQ:XOMA) Files An 8-K Regulation FD Disclosure
Item7.01.
| Regulation FD Disclosure. |
As previously announced, XOMACorporation (XOMA) will participate
in the Cowen Company 37th Annual Health Care Conference in
Boston, Massachusetts. XOMAs Chief Executive Officer, Jim Neal,
is scheduled to make a presentation at the conference onTuesday,
March7, 2017,beginning at 11:20 a.m. EST. A copy of the materials
to be presented at the conference is being furnished as Exhibit
99.1 to this report. Exhibit 99.1 is incorporated by reference
under this Item7.01. Such presentation materials are also
available on XOMAs Investor Relations website
athttp://investors.xoma.com.
The information contained herein is being furnished to Item7.01
of Form 8-K, Regulation FD Disclosure. This information shall not
be deemed to be filed for purposes of Section18 of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or
incorporated by reference in any filing under the Securities Act
of 1933, as amended (the Securities Act), or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.
| Item9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits. |
The exhibit listed below and in the Exhibit Index is being
furnished to Regulation FD as part of this report and shall not
be deemed to be filed for purposes of Section18 of the Exchange
Act or incorporated by reference in any filing under the
Securities Act or the Exchange Act, except as shall be expressly
set forth by specific reference in such a filing.
|
Exhibit Number |
Description of Exhibit | |
| 99.1 |
Investor Materials to be presented at theCowen Company 37th Annual Health Care Conference on March7, 2017 |
XOMA CORPORATION (NASDAQ:XOMA) Recent Trading Information
XOMA CORPORATION (NASDAQ:XOMA) closed its last trading session 00.00 at 4.72 with 45,168 shares trading hands.